Publication

Some observers believe that Mayo v Prometheus will significantly impact research into biotechnology and personalized medicine in the United States. In particular, some believe that patents on diagnostic methods will be difficult to obtain or enforce in the future, dampening incentives to innovate. On the other hand, other commentators believe that Mayo v Prometheus follows established legal principles and appropriately maintains critical medical and scientific data within the public domain. This report will review the Supreme Court’s decision and briefly consider its implications for innovation and public health.